4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Kirn David sold 69,076 4d Molecular Therapeutics, Inc. shares (Form 4)
Traded Aug 19, 2026 · Filed Aug 21, 2026
On Aug 19, 2026, Kirn David (Director, See Remarks) sold 69,076 4d Molecular Therapeutics, Inc. shares at an average US$15.76 for US$1.09M under a trading plan, leaving 825,819 shares. Filed Aug 21, 2026 (Form 4).
- Sold
- 69,076 shares
- Price
- US$15.76 average (US$15.36 to US$16.42)
- Value
- US$1.09M
- Holding after
- 825,819 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Stock | Option exercise | 50,000 | US$4.14 | 894,895 | Direct |
| Aug 19, 2026 | Common Stock | Sale | 43,149 | US$15.36 | 851,746 | Direct |
| Aug 19, 2026 | Common Stock | Sale | 25,927 | US$16.42 | 825,819 | Direct |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Kirn David
- 4d Molecular Therapeutics, Inc. shareholders
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Kirn David · Aug 5, 2026
- Form 4 · Kirn David · Aug 4, 2026
- Form 4 · Kirn David · Jul 14, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Bizily Scott · Sep 3, 2026
- Form 4 · Bizily Scott · Aug 17, 2026
- Form 4 · Bizily Scott · Jul 2, 2026
- Form 4 · Bizily Scott · Jun 25, 2026